Disseminated aspergillosis
ICD-10 B44.0 is a billable code used to indicate a diagnosis of disseminated aspergillosis.
Disseminated aspergillosis is a severe form of fungal infection caused by the Aspergillus species, primarily Aspergillus fumigatus. This condition typically occurs in immunocompromised patients, such as those undergoing chemotherapy, organ transplantation, or those with advanced HIV/AIDS. The infection can spread from the lungs to other organs, including the brain, kidneys, and skin, leading to systemic illness. Symptoms may include fever, cough, chest pain, and respiratory distress, along with signs of organ dysfunction depending on the sites of dissemination. Diagnosis often involves imaging studies, such as CT scans, and microbiological cultures or histopathological examination of tissue samples. Treatment usually requires aggressive antifungal therapy, often with voriconazole or amphotericin B, and may necessitate surgical intervention in cases of localized disease. Early recognition and management are critical to improving outcomes in affected patients.
Detailed clinical notes on the patient's immunocompromised status, diagnostic tests performed, and treatment plans.
Patients presenting with respiratory symptoms and a history of immunosuppression.
Ensure that all diagnostic criteria and treatment responses are well-documented to support coding.
Pulmonary function tests, imaging results, and treatment response notes.
Patients with respiratory distress and confirmed or suspected fungal infections.
Document any co-existing lung conditions that may complicate the diagnosis.
Used when tissue samples are taken for histopathological examination to confirm aspergillosis.
Pathology reports must be included in the medical record.
Ensure that the pathology report clearly indicates the presence of Aspergillus.
Common symptoms include fever, cough, chest pain, and respiratory distress, along with signs of organ dysfunction depending on the sites of dissemination.
Diagnosis typically involves imaging studies, microbiological cultures, and histopathological examination of tissue samples.
Treatment usually requires aggressive antifungal therapy, often with voriconazole or amphotericin B, and may necessitate surgical intervention in cases of localized disease.
